Immunology of Neuroblastoma. Beyond the Immunotherapy

被引：0
|
作者：
Druy, A. [1 ,2 ]
Andreeva, N. [1 ]
Shamanskaya, T. [3 ]
Kachanov, D. [3 ]
机构：
[1] Dmitry Rogachev Natl Med Res Ctr Pediat Hematol O, Mol Oncol Lab, Moscow, Russia
[2] Res Inst Med Cell Technol, Lab Cellular Therapy Oncohematol Disorders, Ekaterinburg, Russia
[3] Dmitry Rogachev Natl Med Res Ctr Pediat Hematol O, Dept Clin Oncol, Moscow, Russia
来源：
PEDIATRIC BLOOD & CANCER | 2020年 / 67卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
0631
引用
收藏
页码：S285 / S285
页数：1
相关论文
共 50 条
  • [21] Effects of the multikinase inhibitor regorafenib in neuroblastoma.
    Zage, Peter E.
    Subramonian, Divya
    Mo, Qianxing
    Huang, Shixia
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [22] Generation and characterization of anti-idiotype antibody ganglidiomab as GD2 surrogate for immunotherapy of neuroblastoma.
    Lode, Holger N.
    Schmidt, Manuela
    Seidel, Diana
    Huebener, Nicole
    Brackrock, Diana
    Bleeke, Matthias
    Reker, Daniel
    Brandt, Sven
    Mueller, Hans-Peter
    Helm, Christiane
    Siebert, Nikolai
    CANCER RESEARCH, 2013, 73
  • [23] Cord blood transplantation for refractory & disseminated neuroblastoma.
    Yu, LC
    BLOOD, 2002, 100 (11) : 464B - 464B
  • [24] ABC drug transporter gene expression in neuroblastoma.
    Cialfi, S.
    McDowell, H. P.
    Altavista, P.
    Boldrini, R.
    Bosco, S.
    Clerico, A.
    Jenkner, A.
    Kokai, G.
    Pizer, B.
    Dominici, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [25] Parental residential pesticide exposure and the risk of neuroblastoma.
    Daniels, JD
    Olshan, AF
    Teschke, T
    Bondy, M
    Shah, N
    Castleberry, RP
    Pollock, BH
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 1998, 147 (11) : S44 - S44
  • [26] Identification of a novel secretory protein specific to neuroblastoma.
    Yang, JH
    Vasudevan, SA
    Liu, ZYJ
    Burlingame, SM
    Patel, PN
    Nuchtern, JG
    CLINICAL CANCER RESEARCH, 2003, 9 (16) : 6239S - 6240S
  • [27] Differentiating agents in pediatric malignancies: retinoids in neuroblastoma.
    Reynolds C.P.
    Current Oncology Reports, 2000, 2 (6) : 511 - 518
  • [28] Haploidentical stem cell transplantation and subsequent immunotherapy with antiGD2 antibody for patients with relapsed metastatic neuroblastoma.
    Lang, Peter
    Illhardt, Toni
    Ebinger, Martin
    Schlegel, Patrick
    Teltschik, Heiko-Manuel
    Feuchtinger, Tobias
    Schwarze, Carl Philipp
    Ladenstein, Ruth L.
    Lode, Holger N.
    Loibner, Hans
    Schwinger, Wolfgang
    Urban, Christian
    Handgretinger, Rupert
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [29] Emergence of new ALK mutations at relapse of neuroblastoma.
    Schleiermacher, Gudrun
    Javanmardi, Niloufar
    Bernard, Virginie
    Leroy, Quentin
    Cappo, Julie
    Rio-Frio, Thomas
    Pierron, Gaelle
    Combaret, Valerie
    Speleman, Frank
    Djos, Anna
    Ora, Ingrid
    Hedborg, Fredrik
    Holmqvist, Britt-Marie
    Abrahamsson, Jonas
    Peuchmaur, Michel
    Michon, Jean
    Janoueix-Lerosey, Isabelle
    Kogner, Per
    Delattre, Olivier
    Martinsson, Tommy
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [30] Monoclonal antibody-based therapy for neuroblastoma.
    Cheung N.K.
    Current Oncology Reports, 2000, 2 (6) : 547 - 553
12345